SE-12C3

N/A

Report date: 2023/12/20 18:00:46

Base Information

Drug NameSE-12C3

Drug Alias NameSE-12C3SE12C3

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionAnti-Signal-regulatory protein alpha

TargetsSignal-regulatory protein alpha

Therapy Area/IndicationsLymphoma, B-CellNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKobe University

China Registration ClassN/A

Active CompaniesKobe University

Inactive CompaniesN/A

Active IndicationsLymphoma, B-Cell

Inactive IndicationsNeoplasms

ATC CodeN/A